"Sjogren's Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.
| Descriptor ID |
D012859
|
| MeSH Number(s) |
C05.550.114.154.774 C05.799.114.774 C07.465.815.929.669 C11.496.260.719 C17.300.775.099.774 C20.111.199.774
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sjogren's Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Sjogren's Syndrome".
This graph shows the total number of publications written about "Sjogren's Syndrome" by people in this website by year, and whether "Sjogren's Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 2 | 0 | 2 |
| 1999 | 0 | 2 | 2 |
| 2001 | 2 | 0 | 2 |
| 2002 | 2 | 1 | 3 |
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2005 | 2 | 0 | 2 |
| 2006 | 1 | 1 | 2 |
| 2007 | 2 | 1 | 3 |
| 2008 | 3 | 0 | 3 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 2 | 4 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 9 | 0 | 9 |
| 2014 | 5 | 0 | 5 |
| 2015 | 3 | 1 | 4 |
| 2016 | 9 | 1 | 10 |
| 2017 | 8 | 1 | 9 |
| 2018 | 7 | 1 | 8 |
| 2019 | 4 | 3 | 7 |
| 2020 | 10 | 0 | 10 |
| 2021 | 9 | 1 | 10 |
| 2022 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sjogren's Syndrome" by people in Profiles.
-
Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells. Nat Commun. 2022 07 27; 13(1):4287.
-
Antibody deposition on vascular endothelial cells contributes to localized inflammation in salivary glands. J Oral Pathol Med. 2022 Aug; 51(7):674-677.
-
X-linked genes exhibit miR6891-5p-regulated skewing in Sjögren's syndrome. J Mol Med (Berl). 2022 Sep; 100(9):1253-1265.
-
Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium. Clin Exp Rheumatol. 2021 Nov-Dec; 39 Suppl 133(6):166-174.
-
Genetic variants at the RTP4/MASP1 locus are associated with fatigue in Scandinavian patients with primary Sjögren's syndrome. RMD Open. 2021 12; 7(3).
-
Childhood-onset of primary Sjögren's syndrome: phenotypic characterization at diagnosis of 158 children. Rheumatology (Oxford). 2021 10 02; 60(10):4558-4567.
-
And Yet It Moves: Oxidation of the Nuclear Autoantigen La/SS-B Is the Driving Force for Nucleo-Cytoplasmic Shuttling. Int J Mol Sci. 2021 Sep 08; 22(18).
-
Defective Efferocytosis in a Murine Model of Sjögren's Syndrome Is Mediated by Dysfunctional Mer Tyrosine Kinase Receptor. Int J Mol Sci. 2021 Sep 08; 22(18).
-
Genetics and epigenetics in primary Sjögren's syndrome. Rheumatology (Oxford). 2021 05 14; 60(5):2085-2098.
-
In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren's syndrome. Rheumatol Int. 2022 03; 42(3):545-551.